Illumina Spin-off to Develop Early-Detection Test
- PMID: 26873346
- DOI: 10.1158/2159-8290.CD-NB2016-015
Illumina Spin-off to Develop Early-Detection Test
Abstract
DNA-sequencing giant Illumina has formed a new company, called Grail, to develop liquid biopsies capable of spotting cancer before symptoms arise. The start-up is working on a low-cost "pan-cancer" test that can detect multiple cancer types early, which it hopes to introduce by 2019.
©2016 American Association for Cancer Research.
Similar articles
-
The Unholy Grail of cancer screening: or is it just about the Benjamins?Clin Chem Lab Med. 2024 Sep 23;63(3):499-506. doi: 10.1515/cclm-2024-1013. Print 2025 Feb 25. Clin Chem Lab Med. 2024. PMID: 39301604
-
Grail to pour $1 billion into blood test to detect early cancer.Nat Biotechnol. 2017 Feb 8;35(2):101-102. doi: 10.1038/nbt0217-101. Nat Biotechnol. 2017. PMID: 28178244 No abstract available.
-
[Cancer screening fantasies].Med Sci (Paris). 2017 Apr;33(4):441-444. doi: 10.1051/medsci/20173304015. Epub 2017 May 12. Med Sci (Paris). 2017. PMID: 28497741 French.
-
Testicular biopsy for early cancer detection--objectives, technique and controversies.Int J Androl. 2011 Aug;34(4 Pt 2):e7-13. doi: 10.1111/j.1365-2605.2011.01152.x. Epub 2011 May 25. Int J Androl. 2011. PMID: 21615417 Review.
-
Core biopsies of the breast: diagnostic pitfalls.Indian J Pathol Microbiol. 2011 Oct-Dec;54(4):671-82. doi: 10.4103/0377-4929.91490. Indian J Pathol Microbiol. 2011. PMID: 22234089 Review.
Cited by
-
Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy.Cancers (Basel). 2019 Feb 7;11(2):196. doi: 10.3390/cancers11020196. Cancers (Basel). 2019. PMID: 30736478 Free PMC article. Review.
-
The Role of Circulating Tumor DNA in Renal Cell Carcinoma.Curr Treat Options Oncol. 2018 Feb 20;19(2):10. doi: 10.1007/s11864-018-0530-4. Curr Treat Options Oncol. 2018. PMID: 29464405 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical